LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Jasper Therapeutics, Inc. ("Jasper†or the "Company†) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the "Class Period†). Jasper investors have until November 18, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS O. ...